Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Rachel L. Cowen"'
Autor:
Gabrielle M Finn, Chiu-Yi Lin, Cinzia Greco, Hema Radhakrishnan, Rachel L Cowen, Natalie J Gardiner
Publikováno v:
BMJ Open, Vol 14, Iss 3 (2024)
Objectives The aim of this study was to explore the barriers and facilitators faced by clinical academics (CAs) in the Greater Manchester region, with particular attention to the experiences of minoritised groups.Design A qualitative study using semi
Externí odkaz:
https://doaj.org/article/e78fae37125742f6bbc5c48d278d2207
Autor:
Amanda Eustace, D.G. Pearson, Chris J. Ottley, Michael J. Tilby, M Barathova, S Brittain-Dissont, Caroline Dive, Ian J. Stratford, Rachel L. Cowen, Kaye J. Williams, Darren L. Roberts
Publikováno v:
British Journal of Cancer
BACKGROUND: Hypoxia is as an indicator of poor treatment outcome. Consistently, hypoxic HCT116 colorectal cancer cells are resistant to oxaliplatin, although the mechanistic basis is unclear. This study sought to investigate the relative contribution
Publikováno v:
Molecular Cancer Therapeutics. 8:1261-1269
Tumor-associated macrophages (TAMs) are found in many solid tumors and have often been shown to accumulate in the hypoxic regions surrounding areas of necrosis. TAMs are the major site of expression of nitric oxide synthase (NOS), a heme-containing h
Publikováno v:
Radiation Research. 171:572-580
Nitric oxide (NO) is a potent radiosensitizer of hypoxic mammalian cells. There have been many reports demonstrating radiosensitization in vitro and in vivo by the use of NO donors to generate NO by chemical means or by producing agents that mimic th
Publikováno v:
Clinical Oncology. 19:427-442
One of the key issues for radiobiologists is the importance of hypoxia to the radiotherapy response. This review addresses the reasons for this and primarily focuses on one aspect, the development of bioreductive drugs that are specifically designed
Autor:
Louisa M. Brown, Kaye J. Williams, Freda C. D. Sheppard, Camille Debray, Amanda Eustace, Janine T. Erler, Ian J. Stratford, Rachel L. Cowen, Catriona Parker
Publikováno v:
Molecular Pharmacology. 69:411-418
The resistance of hypoxic cells to conventional chemotherapy is well documented. Using both adenovirus-mediated gene delivery and small molecules targeting hypoxia-inducible factor-1 (HIF-1), we evaluated the impact of HIF-1 inhibition on the sensiti
Autor:
David J. Waxman, Youssef Jounaidi, Shairoz Ramji, Ian J. Stratford, Rachel L. Cowen, Charles S. Morrow, Adam V. Patterson, Chong-Sheng Chen, Ting Su, Kaye J. Williams, David S. Riddick, Alan J. Townsend, Chunja Lee, Pamela S. Schwartz, E Chinje, Hong Lu
Publikováno v:
Drug Metabolism and Disposition. 33:1083-1096
Drug-metabolizing enzymes and drug transporters are key determinants of the pharmacokinetics and pharmacodynamics of many antineoplastic agents. Metabolism and transport influence the cytotoxic effects of antineoplastic agents in target tumor cells a
Autor:
Ian J. Stratford, Simon D. Scott, Adam V. Patterson, Freda C. D. Sheppard, Rachel L. Cowen, Suzanne Robinson, Naomi Chadderton, Kaye J. Williams, Olga Greco
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 62:213-222
Purpose: Tumor hypoxia is unequivocally linked to poor radiotherapy outcome. This study aimed to identify enhancer sequences that respond maximally to a combination of radiation and hypoxia for use in genetic radiotherapy approaches. Methods and mate
Autor:
Gareth J. Griffiths, Jane Barraclough, Arkadiusz Welman, Christopher Cawthorne, Judith C. Williams, Ian J. Stratford, Caroline Dive, Nigel K Smith, Rachel L. Cowen
Publikováno v:
Journal of Cellular Biochemistry. 94:1148-1162
Validation of targets for cancer drug discovery requires robust experimental models. Systems based on inducible gene expression are well suited to this purpose but are difficult to establish in several epithelial cell types. Using the recently discov
Autor:
E Chinje, Ian J. Stratford, Kaye J. Williams, Rachel L. Cowen, Freda C. D. Sheppard, Natasha S. Wind, Mohammed Jaffar, Brian A. Telfer
Publikováno v:
Cancer Research. 64:1396-1402
Solid tumors are characterized by regions of hypoxia that are inherently resistant to both radiotherapy and some chemotherapy. To target this resistant population, bioreductive drugs that are preferentially toxic to tumor cells in a hypoxic environme